Impending relief for Medicare beneficiaries - the Inflation Reduction Act

New England Journal of Medicine

15 October 2022 - For many Medicare beneficiaries, the Inflation Reduction Act will reduce out of pocket spending for retail prescription drugs, but some effects of the law will have to be carefully monitored by CMS.

Read New England Journal of Medicine Perspective

Michael Wonder

Posted by:

Michael Wonder